<https://www.empr.com/#organization>
<http://schema.org/sameAs>
<https://twitter.com/empr>
<https://www.empr.com/home/news/drugs-in-the-pipeline/voxelotor-gets-priority-review-for-pediatric-sickle-cell-disease/>